Dimensional Fund Advisors LP Pacira Bio Sciences, Inc. Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,049,431 shares of PCRX stock, worth $52.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,049,431
Previous 1,832,216
11.86%
Holding current value
$52.9 Million
Previous $34.5 Million
47.54%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding PCRX
# of Institutions
263Shares Held
48.7MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$207 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$135 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$51.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.97MShares$50.7 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.18B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...